8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Feb 19, 2026·SEC
Material company update
Jan 12, 2026·SEC
GRAIL, Inc.(GRAL)Earnings, Financials & Key Ratios
GRAL•NASDAQ
$62.75
$2.57B mkt cap·Price updated May 6, 2026
AboutGRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.Show more
- Revenue$147M+17.2%
- EBITDA-$378M+81.4%
- Net Income-$408M+79.9%
- EPS (Diluted)-11.11+82.5%
- Gross Margin-42.52%+31.6%
- EBITDA Margin-256.72%+84.1%
- Operating Margin-362.95%+79.2%
- Net Margin-277.47%+82.8%
- ROE-16.07%+75.6%
- ROIC-16.75%+69.4%
- Debt/Equity0.04+39.7%
GRAL Key Insights
GRAIL, Inc. (GRAL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.9x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Shares diluted 15.2% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
GRAL Price & Volume
GRAIL, Inc. (GRAL) stock price & volume — 10-year historical chart
Loading chart...
GRAL Growth Metrics
GRAIL, Inc. (GRAL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years38.37%
TTM17.18%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM79.85%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM82.78%
Return on Capital
10 Years-43.45%
5 Years-41.2%
3 Years-36.43%
Last Year-18.58%
GRAL Recent Earnings
GRAIL, Inc. (GRAL) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (86%)●Beat Revenue 5/12 qtrs (71%)
Q2 2026Latest
May 5, 2026EPS
$2.29
Est $2.76
+17.1%
Revenue
$41M
Est $39M
+4.2%
Q1 2026
Feb 19, 2026EPS
$2.44
Est $3.33
+26.7%
Revenue
$44M
Est $44M
+0.0%
Q4 2025
Nov 12, 2025EPS
$2.46
Est $3.36
+26.8%
Revenue
$36M
Est $35M
+4.6%
Q3 2025
Aug 12, 2025EPS
$3.18
Est $3.14
-1.3%
Revenue
$36M
Est $34M
+4.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $2.29vs $2.76+17.1% | $41Mvs $39M+4.2% |
| Q1 2026 | Feb 19, 2026 | $2.44vs $3.33+26.7% | $44Mvs $44M+0.0% |
| Q4 2025 | Nov 12, 2025 | $2.46vs $3.36+26.8% | $36Mvs $35M+4.6% |
| Q3 2025 | Aug 12, 2025 | $3.18vs $3.14-1.3% | $36Mvs $34M+4.2% |
Based on last 12 quarters of dataView full earnings history →
GRAL Peer Comparison
GRAIL, Inc. (GRAL) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 ILMN | 21.66B | 142.58 | 26.16 | -0.78% | 19.43% | 32.84% | 0.94 | |
 GH | 11.53B | 92.25 | -27.79 | 32.88% | -44.18% | |||
 NTRA | 29.58B | 215.09 | -140.58 | 56.75% | -14.61% | -24.69% | 0.16 | |
 FDMT | 600.27M | 10.42 | -4.31 | 2301.95% | -164.43% | -31.75% | 0.04 | |
 ACMR | 3.67B | 55.38 | 40.42 | 15.24% | 10.44% | 6.11% | 0.16 | |
 CDNA | 1.08B | 20.94 | -52.35 | 13.79% | -1.98% | -2.61% | 0.06 | |
 PACB | 516.17M | 1.71 | -1.60 | -23.19% | -325.8% | -13.95% | 1.33 |
Compare GRAL vs Peers
GRAIL, Inc. (GRAL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GRAL Income Statement
GRAIL, Inc. (GRAL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 14.61M | 55.55M | 93.11M | 125.59M | 147.17M |
| Revenue Growth % | - | - | - | - | 280.17% | 67.61% | 34.9% | 17.18% |
| Cost of Goods Sold | 0 | 0 | 0 | 114.61M | 172M | 188.72M | 203.62M | 209.75M |
| COGS % of Revenue | - | - | - | 784.39% | 309.63% | 202.69% | 162.12% | 142.52% |
| Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | -100M▲ 0% | -116.45M▼ 16.4% | -95.61M▲ 17.9% | -78.02M▲ 18.4% | -62.57M▲ 19.8% |
| Gross Margin % | - | - | - | -684.39% | -209.63% | -102.69% | -62.12% | -42.52% |
| Gross Profit Growth % | - | - | - | - | -16.44% | 17.89% | 18.4% | 19.8% |
| Operating Expenses | 287.5M | 255.66M | 316.42M | 1.17B | 5.33B | 1.42B | 2.11B | 471.59M |
| OpEx % of Revenue | - | - | - | 7975.22% | 9588.56% | 1524.91% | 1680.91% | 320.43% |
| Selling, General & Admin | 64.34M | 88.58M | 123.51M | 234.06M | 296.44M | 362.56M | 367.82M | 275.8M |
| SG&A % of Revenue | - | - | - | 1601.81% | 533.64% | 389.41% | 292.86% | 187.4% |
| Research & Development | 223.16M | 167.09M | 192.91M | 460.21M | 329.58M | 338.75M | 322.38M | 195.79M |
| R&D % of Revenue | - | - | - | 3149.55% | 593.3% | 363.83% | 256.68% | 133.04% |
| Other Operating Expenses | 0 | 0 | 0 | 471.07M | 4.7B | 718.47M | 1.42B | 0 |
| Operating Income | -287.5M▲ 0% | -255.66M▲ 11.1% | -316.42M▼ 23.8% | -1.27B▼ 299.9% | -5.44B▼ 330.2% | -1.52B▲ 72.2% | -2.19B▼ 44.5% | -534.16M▲ 75.6% |
| Operating Margin % | - | - | - | -8659.61% | -9798.18% | -1627.61% | -1743.03% | -362.95% |
| Operating Income Growth % | - | 11.07% | -23.76% | -299.9% | -330.15% | 72.16% | -44.46% | 75.6% |
| EBITDA | -273.42M | -245.36M | -308.85M | -1.21B | -5.29B | -1.36B | -2.03B | -377.82M |
| EBITDA Margin % | - | - | - | -8259.6% | -9519.58% | -1457.16% | -1617.18% | -256.72% |
| EBITDA Growth % | - | 10.26% | -25.88% | -290.77% | -338.16% | 74.34% | -49.71% | 81.4% |
| D&A (Non-Cash Add-back) | 14.08M | 10.31M | 7.56M | 58.45M | 154.76M | 158.7M | 158.06M | 156.34M |
| EBIT | -283.5M | -253.44M | -316.3M | -1.27B | -742.46M | -796.92M | -768.22M | -534.16M |
| Net Interest Income | 8.34M | 12.43M | 6.14M | 332K | 1.74M | 7.95M | 26.73M | 28.65M |
| Interest Income | 8.34M | 12.43M | 6.14M | 332K | 1.74M | 7.95M | 26.73M | 28.65M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 12.26M | 10.61M | 4.29M | 90K | 1.5M | 7.75M | 26.8M | -341K |
| Pretax Income | -275.23M▲ 0% | -245.05M▲ 11.0% | -312.12M▼ 27.4% | -1.27B▼ 305.4% | -5.44B▼ 330.1% | -1.51B▲ 72.3% | -2.16B▼ 43.4% | -534.5M▲ 75.3% |
| Pretax Margin % | - | - | - | -8658.99% | -9795.48% | -1619.29% | -1721.69% | -363.18% |
| Income Tax | 485K | -195K | 33K | -17.48M | -42.29M | -41.95M | -135.36M | -126.15M |
| Effective Tax Rate % | -0.18% | 0.08% | -0.01% | 1.38% | 0.78% | 2.78% | 6.26% | 23.6% |
| Net Income | -275.72M▲ 0% | -244.85M▲ 11.2% | -312.16M▼ 27.5% | -1.25B▼ 299.7% | -5.4B▼ 332.7% | -1.47B▲ 72.9% | -2.03B▼ 38.3% | -408.35M▲ 79.9% |
| Net Margin % | - | - | - | -8539.39% | -9719.35% | -1574.23% | -1613.92% | -277.47% |
| Net Income Growth % | - | 11.19% | -27.49% | -299.73% | -332.7% | 72.85% | -38.3% | 79.85% |
| Net Income (Continuing) | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B | -408.35M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.42▲ 0% | -1.99▲ 17.8% | -2.52▼ 26.6% | -40.18▼ 1494.4% | -173.87▼ 332.7% | -47.20▲ 72.9% | -63.54▼ 34.6% | -11.11▲ 82.5% |
| EPS Growth % | - | 17.77% | -26.63% | -1494.44% | -332.73% | 72.85% | -34.62% | 82.52% |
| EPS (Basic) | -2.42 | -1.99 | -2.52 | -40.18 | -173.87 | -47.20 | -63.54 | -11.11 |
| Diluted Shares Outstanding | 114.14M | 123.19M | 123.67M | 31.05M | 31.05M | 31.05M | 31.9M | 36.75M |
| Basic Shares Outstanding | 114.14M | 123.19M | 123.67M | 31.05M | 31.05M | 31.05M | 31.9M | 36.75M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
GRAL Balance Sheet
GRAIL, Inc. (GRAL) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 649.23M | 557.51M | 595.92M | 242.73M | 295.63M | 156.06M | 819.86M | 953.85M |
| Cash & Short-Term Investments | 641.35M | 544.34M | 583.48M | 221.16M | 241.6M | 97.29M | 763.47M | 904.43M |
| Cash Only | 95.09M | 143.19M | 170.19M | 221.16M | 241.6M | 97.29M | 214.23M | 249.73M |
| Short-Term Investments | 546.26M | 401.15M | 413.29M | 0 | 0 | 0 | 549.24M | 654.7M |
| Accounts Receivable | 0 | 0 | 0 | 6.88M | 18.61M | 22.35M | 24.64M | 18.3M |
| Days Sales Outstanding | - | - | - | 171.91 | 122.31 | 87.63 | 71.61 | 45.37 |
| Inventory | 0 | 0 | 0 | 0 | 19.75M | 21.7M | 18.63M | 16.02M |
| Days Inventory Outstanding | - | - | - | - | 41.92 | 41.96 | 33.4 | 27.87 |
| Other Current Assets | 0 | 0 | 0 | 6.89M | 0 | 0 | 0 | 15.11M |
| Total Non-Current Assets | 37.61M | 78.01M | 110.38M | 9.5B | 5.31B | 4.4B | 2.16B | 1.97B |
| Property, Plant & Equipment | 33.04M | 59.46M | 101.39M | 216.37M | 198.72M | 169.38M | 135.43M | 103.88M |
| Fixed Asset Turnover | - | - | - | 0.07x | 0.28x | 0.55x | 0.93x | 1.42x |
| Goodwill | 0 | 0 | 0 | 6.2B | 1.5B | 888.94M | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 3.07B | 2.94B | 2.69B | 2.02B | 1.85B |
| Long-Term Investments | 1.63M | 15.16M | 2.05M | 0 | 4.53M | 4.22M | 0 | 6.97M |
| Other Non-Current Assets | 2.94M | 3.38M | 6.94M | 7.1M | 6.14M | 7.98M | 11.12M | 6.75M |
| Total Assets | 686.85M▲ 0% | 635.52M▼ 7.5% | 706.3M▲ 11.1% | 9.74B▲ 1278.7% | 5.6B▼ 42.5% | 4.56B▼ 18.7% | 2.98B▼ 34.5% | 2.92B▼ 2.1% |
| Asset Turnover | - | - | - | 0.00x | 0.01x | 0.02x | 0.04x | 0.05x |
| Asset Growth % | - | -7.47% | 11.14% | 1278.73% | -42.47% | -18.66% | -34.53% | -2.05% |
| Total Current Liabilities | 74.16M | 44.93M | 83.97M | 97.89M | 134.94M | 163.61M | 76.92M | 79.67M |
| Accounts Payable | 12.75M | 6.09M | 24.51M | 17.65M | 17.48M | 19.67M | 4.84M | 2.08M |
| Days Payables Outstanding | - | - | - | 56.2 | 37.1 | 38.05 | 8.68 | 3.62 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 13.34M | 14.81M | 0 | 11.71M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 1.6M | 0 |
| Other Current Liabilities | 267K | 23K | 12.41M | 4.51M | 65.96M | 87.64M | 22.69M | 65.87M |
| Current Ratio | 8.75x | 12.41x | 7.10x | 2.48x | 2.19x | 0.95x | 10.66x | 11.97x |
| Quick Ratio | 8.75x | 12.41x | 7.10x | 2.48x | 2.04x | 0.82x | 10.42x | 11.77x |
| Cash Conversion Cycle | - | - | - | - | 127.14 | 91.54 | 96.33 | 69.62 |
| Total Non-Current Liabilities | 12.32M | 40.06M | 60.49M | 209.51M | 821M | 747.13M | 402.98M | 264.48M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.15M |
| Capital Lease Obligations | 800K | 36.64M | 57.54M | 96.75M | 82.67M | 69.6M | 54.88M | 43.15M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 735.19M | 676.03M | 345.86M | 218.58M |
| Other Non-Current Liabilities | 11.52M | 3.42M | 2.95M | 112.76M | 3.13M | 1.5M | 2.24M | -40.4M |
| Total Liabilities | 86.47M | 84.99M | 144.46M | 307.4M | 955.94M | 910.74M | 479.9M | 344.15M |
| Total Debt | 2.52M | 42.04M | 62.99M | 110.56M | 96.01M | 84.41M | 68.14M | 98.01M |
| Net Debt | -92.57M | -101.15M | -107.21M | -110.6M | -145.59M | -12.88M | -146.09M | -151.72M |
| Debt / Equity | 0.00x | 0.08x | 0.11x | 0.01x | 0.02x | 0.02x | 0.03x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | 600.37M▲ 0% | 550.53M▼ 8.3% | 561.84M▲ 2.1% | 9.43B▲ 1578.5% | 4.65B▼ 50.7% | 3.65B▼ 21.5% | 2.5B▼ 31.3% | 2.58B▲ 3.0% |
| Equity Growth % | - | -8.3% | 2.05% | 1578.52% | -50.73% | -21.52% | -31.34% | 2.97% |
| Book Value per Share | 5.26 | 4.47 | 4.54 | 303.69 | 149.62 | 117.42 | 78.47 | 70.14 |
| Total Shareholders' Equity | 600.37M | 550.53M | 561.84M | 9.43B | 4.65B | 3.65B | 2.5B | 2.58B |
| Common Stock | 129K | 138K | 151K | 10.34B | 10.96B | 11.42B | 34K | 40K |
| Retained Earnings | -1.06B | -1.31B | -1.62B | -911.54M | -6.31B | -7.78B | -9.8B | -10.21B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 128K | 2.46M | 3.6M | 315K | 894K | 1.07M | 1.45M | 2.65M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GRAL Cash Flow Statement
GRAIL, Inc. (GRAL) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -209.26M | -245.79M | -232M | -688.13M | -561.31M | -595.8M | -577.16M | -299.01M |
| Operating CF Margin % | - | - | - | -4709.35% | -1010.46% | -639.92% | -459.54% | -203.17% |
| Operating CF Growth % | - | -17.46% | 5.61% | -196.61% | 18.43% | -6.14% | 3.13% | 48.19% |
| Net Income | -275.72M | -244.85M | -312.16M | -1.25B | -5.4B | -1.47B | -2.03B | -408.35M |
| Depreciation & Amortization | 14.08M | 10.31M | 7.56M | 58.45M | 154.76M | 158.7M | 158.06M | 0 |
| Stock-Based Compensation | 11.04M | 28.39M | 45.99M | 681.91M | 75.73M | 97.23M | 86.08M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | -39.06M | -38.15M | -134.25M | 0 |
| Other Non-Cash Items | 1.66M | -353K | 9.38M | -201M | 4.66B | 644.38M | 1.36B | 96.94M |
| Working Capital Changes | 39.67M | -39.28M | 17.22M | 20.29M | -14.46M | 7.72M | -24.28M | 12.41M |
| Change in Receivables | 0 | 0 | 0 | -6.88M | -8.68M | -1.38M | -3.37M | 1.69M |
| Change in Inventory | 0 | 0 | 0 | -5.67M | -14.08M | -1.94M | 3.07M | 2.62M |
| Change in Payables | -338K | -6.55M | 0 | 0 | 2.34M | 2.89M | -14.63M | -2.73M |
| Cash from Investing | -93.39M | 133.04M | -12.79M | 344.81M | -22.86M | -12.89M | -551.01M | -85.05M |
| Capital Expenditures | -15.99M | -3.33M | -11.9M | -69.93M | -22.86M | -12.89M | -5.21M | -909K |
| CapEx % of Revenue | - | - | - | 478.55% | 41.15% | 13.84% | 4.15% | 0.62% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | -77.4M | 136.37M | -885K | 414.74M | 0 | 0 | 0 | 0 |
| Cash from Financing | 300.62M | 160.33M | 275.11M | 394.74M | 604.82M | 463.77M | 1.24B | 423.32M |
| Debt Issued (Net) | -1.51M | -1.56M | -812K | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 5.81M | 0 | 0 | 0 | 423.32M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -170K | 0 | 0 | 0 | 0 |
| Other Financing | 302.13M | 161.88M | 275.92M | 388.93M | 604.82M | 463.77M | 1.24B | 0 |
| Net Change in Cash | -1.55M▲ 0% | 47.69M▲ 3179.0% | 30.35M▼ 36.4% | -143.19M▼ 571.8% | 20.13M▲ 114.1% | -144.62M▼ 818.3% | 116.07M▲ 180.3% | 39.12M▼ 66.3% |
| Free Cash Flow | -225.25M▲ 0% | -249.13M▼ 10.6% | -243.91M▲ 2.1% | -758.06M▼ 210.8% | -584.17M▲ 22.9% | -608.69M▼ 4.2% | -582.36M▲ 4.3% | -299.01M▲ 48.7% |
| FCF Margin % | - | - | - | -5187.9% | -1051.61% | -653.76% | -463.68% | -203.17% |
| FCF Growth % | - | -10.6% | 2.09% | -210.8% | 22.94% | -4.2% | 4.32% | 48.66% |
| FCF per Share | -1.97 | -2.02 | -1.97 | -24.41 | -18.81 | -19.60 | -18.26 | -8.14 |
| FCF Conversion (FCF/Net Income) | 0.76x | 1.00x | 0.74x | 0.55x | 0.10x | 0.41x | 0.28x | 0.73x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GRAL Key Ratios
GRAIL, Inc. (GRAL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -45.92% | -42.55% | -56.12% | -24.97% | -76.71% | -35.35% | -65.92% | -16.07% |
| Return on Invested Capital (ROIC) | -42.46% | -40.06% | -52.5% | -19.42% | -59.07% | -27.95% | -54.81% | -16.75% |
| Gross Margin | - | - | - | -684.39% | -209.63% | -102.69% | -62.12% | -42.52% |
| Net Margin | - | - | - | -8539.39% | -9719.35% | -1574.23% | -1613.92% | -277.47% |
| Debt / Equity | 0.00x | 0.08x | 0.11x | 0.01x | 0.02x | 0.02x | 0.03x | 0.04x |
| FCF Conversion | 0.76x | 1.00x | 0.74x | 0.55x | 0.10x | 0.41x | 0.28x | 0.73x |
| Revenue Growth | - | - | - | - | 280.17% | 67.61% | 34.9% | 17.18% |
GRAL SEC Filings & Documents
GRAIL, Inc. (GRAL) SEC filings — annual & quarterly reports (10-K, 10-Q)
GRAL Frequently Asked Questions
GRAIL, Inc. (GRAL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
GRAIL, Inc. (GRAL) reported $147.2M in revenue for fiscal year 2025.
GRAIL, Inc. (GRAL) grew revenue by 17.2% over the past year. This is strong growth.
GRAIL, Inc. (GRAL) reported a net loss of $408.4M for fiscal year 2025.
Dividend & Returns
GRAIL, Inc. (GRAL) has a return on equity (ROE) of -16.1%. Negative ROE indicates the company is unprofitable.
GRAIL, Inc. (GRAL) had negative free cash flow of $299.0M in fiscal year 2025, likely due to heavy capital investments.
Explore More GRAL
GRAIL, Inc. (GRAL) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates